Back to Journals » Breast Cancer: Targets and Therapy » Volume 15
Original Research
Invasive Breast Cancer with HER2 ≥4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
3,255 | Dovepress* | 3,129+ | 138 | 3,267 | |
PubMed Central* | 126 | 91 | 217 | ||
Totals | 3,255 | 229 | 3,484 | ||
*Since 3 August 2023 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar